Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Dermaliq Therapeutics's investors include 3E Bioventures, DEBRA Research, Beijing Whale Technology Corporation.
Dermaliq Therapeutics is headquartered in Wilmington, United States.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Dermaliq Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dermaliq Therapeutics — Funding & Investors." VCBacked, May 28, 2025, https://www.vcbacked.co/company/dermaliq-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Dermaliq Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/dermaliq-therapeutics
{{cite web |title=Dermaliq Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dermaliq-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated